Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

31
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Statement of the Austrian Society of Pneumology expert group for interstitial lung diseases and orphan diseases on the 2025 update of the international multidisciplinary classification of interstitial pneumonias].

Wiener klinische Wochenschrift·2026
Same author

Correction: Case Report: Diagnostic challenges in VEXAS syndrome with novel ultrastructural lung findings: IgG4-RD and vasculitis as relevant differential diagnoses.

Frontiers in immunology·2026
Same author

Values-Based Healthcare and the Quintuple Aim: Connection, Compassion, Equity, & Stewardship.

The journal of allergy and clinical immunology. In practice·2026
Same author

Digitally enhanced fracture liaison service in Austria-a feasibility analysis.

Archives of osteoporosis·2026
Same author

Statin use and its implications on survival and disease progression in the European MultiPartner idiopathic pulmonary fibrosis registry (EMPIRE).

Annals of medicine·2026
Same author

Low-Dose Methotrexate and Bone Health: Pathophysiological and Clinical Perspectives.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Mar 24, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K

IgG4-related disease: current challenges and future prospects.

David Lang1, Jochen Zwerina2, Herwig Pieringer3

  • 1Second Department of Internal Medicine, Kepler University Clinic, Linz, Austria.

Therapeutics and Clinical Risk Management
|March 2, 2016
PubMed
Summary

Immunoglobulin G4-related disease (IgG4-RD) is a complex immune condition affecting multiple organs. Recent advances improve understanding of its epidemiology, diagnosis, and treatment, though more research is needed.

Keywords:
PET/CTautoimmune pancreatitisplasmablastrituximab

More Related Videos

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

2.0K
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

4.1K

Related Experiment Videos

Last Updated: Mar 24, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

2.0K
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

4.1K

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Background:

  • Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory condition with diverse organ manifestations.
  • While recognized as a distinct entity recently, its epidemiology and pathophysiology remain incompletely understood.
  • Diagnosis is challenging, requiring integrated clinical, imaging, histological, and serological data, with no single specific marker.

Purpose of the Study:

  • To provide a comprehensive overview of current knowledge on IgG4-RD.
  • To highlight recent advancements in diagnostic criteria, immunological insights, biomarkers, and therapies.
  • To discuss unanswered questions and future research directions in IgG4-RD.

Main Methods:

  • Literature review of recent advancements in IgG4-RD.
  • Synthesis of current understanding of epidemiology, pathophysiology, diagnosis, and therapy.
  • Identification of knowledge gaps and future research perspectives.

Main Results:

  • Significant progress has been made in understanding IgG4-RD's immunological basis, diagnostic approaches, and therapeutic strategies.
  • New diagnostic criteria, biomarkers, and treatments have been proposed.
  • Despite advances, many aspects of IgG4-RD require further investigation and clinical validation.

Conclusions:

  • IgG4-RD is an evolving field with rapid advancements.
  • Further clinical trials are essential to validate new findings and refine management strategies.
  • Continued research is crucial for a complete understanding and effective treatment of IgG4-RD.